Literature DB >> 7903056

Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes.

H Zhang1, Y Xiong, D Beach.   

Abstract

We have recently shown that two proteins, proliferating cell nuclear antigen (PCNA) and p21, are associated with cyclin D. Here we show that PCNA and p21 are common components of a wide variety of cyclin/cyclin-dependent kinase complexes in nontransformed cells. These include kinase complexes containing cyclin A, cyclin B, and cyclin D, associated either with CDC2, CDK2, CDK4, or CDK5. We show that PCNA and p21 form separate quaternary complex with each cyclin/CDK and that these quaternary complexes contain a substantial, if not major, fraction of the cell cycle kinases in asynchronously growing cells. These results suggest that PCNA and p21 may perform a common function for all these kinases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903056      PMCID: PMC275720          DOI: 10.1091/mbc.4.9.897

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  61 in total

1.  The roles of Drosophila cyclins A and B in mitotic control.

Authors:  C F Lehner; P H O'Farrell
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

Review 2.  Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation.

Authors:  G Draetta
Journal:  Trends Biochem Sci       Date:  1990-10       Impact factor: 13.807

3.  Human cDNAs encoding homologs of the small p34Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe.

Authors:  H E Richardson; C S Stueland; J Thomas; P Russell; S I Reed
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

4.  Cloning by differential screening of a Xenopus cDNA coding for a protein highly homologous to cdc2.

Authors:  J Paris; R Le Guellec; A Couturier; K Le Guellec; F Omilli; J Camonis; S MacNeill; M Philippe
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

5.  Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B.

Authors:  J Pines; T Hunter
Journal:  Nature       Date:  1990-08-23       Impact factor: 49.962

6.  The role of CDC28 and cyclins during mitosis in the budding yeast S. cerevisiae.

Authors:  U Surana; H Robitsch; C Price; T Schuster; I Fitch; A B Futcher; K Nasmyth
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

7.  A cyclin B homolog in S. cerevisiae: chronic activation of the Cdc28 protein kinase by cyclin prevents exit from mitosis.

Authors:  J B Ghiara; H E Richardson; K Sugimoto; M Henze; D J Lew; C Wittenberg; S I Reed
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

8.  A novel cyclin encoded by a bcl1-linked candidate oncogene.

Authors:  T Motokura; T Bloom; H G Kim; H Jüppner; J V Ruderman; H M Kronenberg; A Arnold
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

9.  The A- and B-type cyclin associated cdc2 kinases in Xenopus turn on and off at different times in the cell cycle.

Authors:  J Minshull; R Golsteyn; C S Hill; T Hunt
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

10.  A family of human cdc2-related protein kinases.

Authors:  M Meyerson; G H Enders; C L Wu; L K Su; C Gorka; C Nelson; E Harlow; L H Tsai
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  100 in total

1.  Extracellular matrix modulates enterocyte growth via downregulation of c-jun but is independent of p21 and p27 expression.

Authors:  S I Wolpert; K M Lally; J Li; J Y Wang; B L Bass
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

Review 2.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 3.  Gadd45 proteins: relevance to aging, longevity and age-related pathologies.

Authors:  Alexey A Moskalev; Zeljka Smit-McBride; Mikhail V Shaposhnikov; Ekaterina N Plyusnina; Alex Zhavoronkov; Arie Budovsky; Robi Tacutu; Vadim E Fraifeld
Journal:  Ageing Res Rev       Date:  2011-10-05       Impact factor: 10.895

4.  Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.

Authors:  Vanisri Raviraj; Hui Zhang; Hsin-ya Chien; Louise Cole; Erik W Thompson; Lilian Soon
Journal:  Clin Exp Metastasis       Date:  2012-01-22       Impact factor: 5.150

5.  ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.

Authors:  Valerie S Hawthorne; Wen-Chien Huang; Christopher L Neal; Ling-Min Tseng; Mien-Chie Hung; Dihua Yu
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

6.  Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity.

Authors:  Kathy Q Cai; Hong Wu; Andres J Klein-Szanto; Xiang-Xi Xu
Journal:  Gynecol Oncol       Date:  2009-04-16       Impact factor: 5.482

7.  Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1.

Authors:  J Y Su; R E Rempel; E Erikson; J L Maller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter.

Authors:  C Labrie; B H Lee; M B Mathews
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

9.  Oncogenic capacity of the E2F1 gene.

Authors:  D G Johnson; W D Cress; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo.

Authors:  J Chen; R Peters; P Saha; P Lee; A Theodoras; M Pagano; G Wagner; A Dutta
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.